Anti-depressants, selective serotonin reuptake inhibitors - Index

Printer-friendly version

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

Revision history
- April 28, 2023
- April 23, 2021
- March 2019
Initially developed
- March 2017